
    
      PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive
      an infusion of either pertussis immune globulin or placebo (0.9% saline).

      Patients are followed every 2 weeks for up to 6 months.

      Completion date provided represents the completion date of the grant per OOPD records
    
  